NASDAQ : LUCD
Lucid Diagnostics Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.4323 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 82.55M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 77.58M |
| Enterprise Value | 68.02M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 190.95M |
| Shares Outstanding | 190.95M |
| Shares Change (YoY) | +103.51% |
| Shares Change (QoQ) | +30.71% |
| Owned by Insiders (%) | 5.95% |
| Owned by Institutions (%) | 32.75% |
| Float | 140.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.31 |
| Forward PS | 8.54 |
| PB Ratio | 7.07 |
| P/TBV Ratio | 7.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 12.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.33 |
| Quick Ratio | 1.29 |
| Debt / Equity | 2.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,815.72 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -556.27% |
| Return on Assets (ROA) | -81.62% |
| Return on Invested Capital (ROIC) | -88.92% |
| Return on Capital Employed (ROCE) | -443.42% |
| Weighted Average Cost of Capital (WACC) | 7.92% |
| Revenue Per Employee | $66,402 |
| Profits Per Employee | -$792,756 |
| Employee Count | 82 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 13.40 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -66.42% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 1.02 |
| Relative Strength Index (RSI) | 36.04 |
| Average Volume (20 Days) | 12,998,116 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 13.63M |
| Short Previous Month | 13.46M |
| Short % of Shares Out | 7.14% |
| Short % of Float | 9.68% |
| Short Ratio (days to cover) | 7.50 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.45M |
| Gross Profit | -1.18M |
| Operating Income | -50.68M |
| Pretax Income | -52.26M |
| Net Income | -65.01M |
| EBITDA | -49.81M |
| EBIT | -50.68M |
| Loss Per Share | -$0.46 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 34.47M |
| Total Debt | 24.91M |
| Net Cash | 9.56M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 10.93M |
| Book Value Per Share | 0.06 |
| Working Capital | 9.11M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -46.87M |
| Capital Expenditures | -315,000 |
| Depreciation & Amortization | 875,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -47.18M |
| FCF Per Share | -$0.25 |
Margins
| Measure | Value |
|---|
| Gross Margin | -21.69% |
| Operating Margin | -930.82% |
| Pretax Margin | -959.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -103.51% |
| Shareholder Yield | -103.51% |
| Earnings Yield | -113.61% |
| FCF Yield | -60.55% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.00 |
| Price Target Difference | 884.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 91.81% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -11.71 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |